| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.IJO.0802265 |
| P953 | full work available at URL | http://www.nature.com/articles/0802265 |
| http://www.nature.com/articles/0802265.pdf | ||
| P698 | PubMed publication ID | 12704399 |
| P50 | author | Yoshihiro Ogawa | Q96682708 |
| P2093 | author name string | K. Nakao | |
| T. Nakagawa | |||
| M. Yamanaka | |||
| H. Noguchi | |||
| A. Tsuchida | |||
| K. Ebihara | |||
| M. Taiji | |||
| P2860 | cites work | Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity | Q22241899 |
| Positional cloning of the mouse obese gene and its human homologue | Q22251285 | ||
| Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity | Q24617406 | ||
| The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors | Q24629394 | ||
| Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity | Q24635198 | ||
| Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor | Q28239346 | ||
| Divergent signaling capacities of the long and short isoforms of the leptin receptor | Q28610099 | ||
| Serum immunoreactive-leptin concentrations in normal-weight and obese humans | Q29617230 | ||
| Weight-reducing effects of the plasma protein encoded by the obese gene | Q29617934 | ||
| Effects of the obese gene product on body weight regulation in ob/ob mice | Q29617935 | ||
| Congenital leptin deficiency is associated with severe early-onset obesity in humans | Q29618702 | ||
| Obesity and the regulation of energy balance | Q30080025 | ||
| Effects of recombinant leptin therapy in a child with congenital leptin deficiency. | Q33874084 | ||
| Systemic administration of ciliary neurotrophic factor induces cachexia in rodents | Q34152969 | ||
| BDNF regulates eating behavior and locomotor activity in mice | Q34667950 | ||
| Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance | Q36188464 | ||
| Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities | Q36784651 | ||
| Diet-induced obese mice develop peripheral, but not central, resistance to leptin | Q37362925 | ||
| The Trk family of neurotrophin receptors | Q40590908 | ||
| Physiology of the neurotrophins | Q41132669 | ||
| The neurotrophins and CNTF: two families of collaborative neurotrophic factors | Q41132721 | ||
| Genetics of obesity: advances from rodent studies | Q41279322 | ||
| Signal transduction events mediated by the BDNF receptor gp 145trkB in primary hippocampal pyramidal cell culture | Q42805837 | ||
| Diet-induced type II diabetes in C57BL/6J mice | Q45730735 | ||
| Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial | Q47254016 | ||
| Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system | Q47772359 | ||
| Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice | Q48263992 | ||
| Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons | Q48578988 | ||
| Melanocortin receptors in leptin effects | Q48590178 | ||
| Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity | Q48601029 | ||
| Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice | Q48627355 | ||
| Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes. | Q52896075 | ||
| Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. | Q54079619 | ||
| A leptin missense mutation associated with hypogonadism and morbid obesity. | Q55067416 | ||
| Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice | Q59328728 | ||
| Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice | Q73384110 | ||
| Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice | Q73929133 | ||
| Acute effects of brain-derived neurotrophic factor on energy expenditure in obese diabetic mice | Q74554905 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 557-565 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity | Q27710118 |
| P1476 | title | Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance | |
| Antiobesity and antidiabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance | |||
| P478 | volume | 27 |
| Q24650481 | A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults |
| Q34734974 | Activation of TrkB with TAM-163 results in opposite effects on body weight in rodents and non-human primates |
| Q43373021 | Antidiabetic Effect of Brain-Derived Neurotrophic Factor and Its Association with Inflammation in Type 2 Diabetes Mellitus |
| Q36796000 | BDNF action in the brain attenuates diabetic hyperglycemia via insulin-independent inhibition of hepatic glucose production |
| Q35673792 | Brain-derived neurotrophic factor (BDNF) in the hypothalamic ventromedial nucleus increases energy expenditure |
| Q36418981 | Brain-derived neurotrophic factor and its clinical implications |
| Q33841075 | Chronic administration of brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus reverses obesity induced by high-fat diet |
| Q45957461 | Diminished hypothalamic bdnf expression and impaired VMH function are associated with reduced SF-1 gene dosage. |
| Q46244212 | Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences |
| Q38168376 | From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF) |
| Q92155440 | Health Benefits of Endurance Training: Implications of the Brain-Derived Neurotrophic Factor-A Systematic Review |
| Q38997785 | Impact of intermittent fasting on health and disease processes |
| Q95792677 | Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women |
| Q41205365 | Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus? |
| Q36501750 | Mechanism of hyperphagia contributing to obesity in brain-derived neurotrophic factor knockout mice |
| Q47103932 | Molecular Therapy of Melanocortin-4-Receptor Obesity by an Autoregulatory BDNF Vector |
| Q36705780 | Molecular and neural bases underlying roles of BDNF in the control of body weight |
| Q41888000 | Molecular therapy of obesity and diabetes by a physiological autoregulatory approach |
| Q37025375 | Neuronal control of energy homeostasis |
| Q36616975 | New aspects of melanocortin signaling: A role for PRCP in α-MSH degradation |
| Q44859567 | Physiological and neurobiological elements of food intake |
| Q36378196 | Plasma brain-derived neurotrophic factor in hemodialysis patients |
| Q37698685 | Progress in the genetics of common obesity and type 2 diabetes |
| Q40122700 | The brain-liver connection between BDNF and glucose control |
| Q35801796 | The lighter side of BDNF. |
| Q28505415 | p75 neurotrophin receptor regulates glucose homeostasis and insulin sensitivity |
Search more.